Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Egypt’s Medical Tourism Push Gains Momentum, but Still Trails Global Leaders
Egypt’s medical‑tourism sector surged in 2025, with revenues jumping 76.7% to roughly $8 million. The growth is driven by a government push to market affordable, high‑quality care to nearby Gulf and African nations, leveraging the country’s tourism infrastructure. A new national digital platform and dedicated health‑tourism zones aim to streamline bookings and attract private investment. Despite the momentum, Egypt remains a niche player compared with established hubs like Turkey, India and Thailand.
Hard-to-Measure ROI Stifles Life‑Saving Healthcare Innovation
I've seen hospital CEOs cancel innovations that reduced readmissions and ED visits. The outcomes were incredible - but the financial ROI was too hard to prove. And since "ROI is needed to justify everything right now in healthcare" many great innovations...
Thousands of Americans Treated With Psilocybin in 2025
Psilocybin therapy is rapidly expanding across U.S. states, with Oregon reporting 5,935 patients in 2025 and Colorado opening its first regulated healing center. New Mexico is developing its own medical program while the federal government maintains prohibition. Scientific evidence shows...
WHO Member States Agree to Extend Negotiations on Key Annex to the Pandemic Agreement
World Health Organization Member States have agreed to extend negotiations on the Pathogen Access and Benefit Sharing (PABS) annex of the WHO Pandemic Agreement, with talks slated for 27 April – 1 May and informal sessions beforehand. The extension aims to finalize an ambitious,...
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
Takeda announced Phase 3 data for its oral TYK2 inhibitor, zasocitinib, showing rapid and durable skin clearance in moderate‑to‑severe plaque psoriasis. At week 16, 71% of patients achieved clear or almost clear skin (sPGA 0/1) versus roughly 10% on placebo and 30% on...
Can You Change an 88-Year-Old Brain?
An 88‑year‑old civil‑rights veteran used an AI‑powered dyslexia program and saw his reading accuracy jump from 50 % to 80 % in phonemic awareness. Clinical evidence shows that neuroplasticity remains viable in seniors, allowing language‑based cognitive training to improve reading and memory...
Icotrokinra Delivers Complete Skin Clearance Through Week 52 With Strong Safety Profile: Linda Stein Gold, MD
FDA approval of icotrokinra introduces a new oral therapy for moderate‑to‑severe psoriasis. In the ICONIC‑ADVANCE trials, 100 % of patients achieved complete skin clearance through week 52, outperforming the oral benchmark deucravacitinib. The drug’s safety profile matched placebo, with fewer infections and...
Q&A: How Dermatologists Can Navigate Gender-Affirming Care Today
Dermatologists are facing a rapidly shifting regulatory environment as dozens of states enact bans or restrictions on gender‑affirming care, affecting roughly 40% of transgender youth. Dr. Klint Peebles emphasizes that precise, evidence‑based documentation is essential to protect clinicians and ensure...
Can Deep Brain Stimulation Unlock Treatment-Resistant Depression?
Approximately 30% of depression patients are treatment‑resistant, prompting research into deep brain stimulation (DBS) as a new therapeutic avenue. DBS, already FDA‑approved for movement disorders, delivers electrical pulses to white‑matter tracts to “unstick” the brain, with effects developing over weeks...
Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College...
Arrowhead Pharmaceuticals presented two‑year open‑label extension data for plozasiran at the ACC 75th session, showing an 83% median triglyceride reduction in severe hypertriglyceridemia and 96% of patients dropping below the 500 mg/dL pancreatitis threshold. No adjudicated acute pancreatitis events occurred, and...
How High Taxes and the California Medical Board Fuel the Physician Shortage
California physicians face a perfect storm of low Medi‑Cal reimbursements, the nation’s highest marginal tax rate, and soaring housing costs that erode take‑home pay. At the same time, the California Medical Board processes nearly 10,000 complaints annually, with about 1,000...
Canada Proposes Minors' Right to Choose Assisted Death
Brochure for assisted suicide for children and teens in Canada. The 2023 Special Joint Committee on MAiD recommended allowing "mature minors" (capable children, often referenced as 12+) access if death is reasonably foreseeable, consulting parents "where appropriate" but letting the child's...
Stability of Immature Platelets Present in Single Donor Units During Hemoconcentration
The study examined how routine plasma‑reduction and centrifugation affect immature platelets in single‑donor units. Centrifugation increased platelet concentration per milliliter, while total counts of both platelets and immature platelets remained unchanged. The ratio of immature to mature platelets and their...
A Latent Profile Analysis of Prenatal Depression and Anxiety in Chinese Women with Twin Pregnancies
A cross‑sectional study of 334 Chinese women carrying twins applied latent profile analysis to uncover distinct patterns of prenatal depression and anxiety. Researchers identified two subgroups: a low‑risk group comprising 65% of participants and a high‑risk group representing 35%. Multivariate...
Validation of the First Brazilian Instrument for Patient Engagement in Patient Safety
Researchers have produced a Brazilian Portuguese version of the Patient Engagement in Patient Safety tool, adapting it through a six‑step cross‑cultural process and validating it with a Delphi panel of seven experts. The adaptation achieved 97.9% item equivalence, while content...
Assessment of Caregiver Burden Amongst Parents of Children With Congenital Heart Disease in Two Tertiary Hospitals in Nigeria: A Cross-...
A cross‑sectional study of 100 primary caregivers at two Nigerian tertiary hospitals measured caregiver burden among parents of children with congenital heart disease (CHD). The research found that 41% of caregivers experienced moderate burden and 26% severe burden, with emotional/psychological...
Manual Pressure Techniques Activate Descending Pain-Modulatory Pathways and Reduce Headache Intensity in Chronic Tension-Type Headache: A Randomized Crossover Trial
A randomized crossover trial involving 37 chronic tension‑type headache patients found that manual pressure techniques and the cold pressor test both elevated pressure pain thresholds, indicating activation of descending pain‑modulatory pathways. However, only manual pressure produced a statistically significant reduction...
Psychological Empowerment as a Moderator in the Pathway From Attitudes Toward Care of the Dying to Palliative Care Competency Among...
A cross‑sectional survey of 996 nursing interns from 42 Chinese teaching hospitals examined how attitudes toward caring for the dying influence palliative care competence. The study found a strong positive effect (β = 0.594) and identified self‑efficacy and psychological resilience as sequential...
Real-World Patterns of Peri-Procedural Antiplatelet Therapy and Concomitant Verapamil Use During Transradial Percutaneous Coronary Intervention
A single‑center retrospective study of 204 transradial PCI cases (2024‑25) found verapamil used in 98.5% of procedures. Ticagrelor was administered in 33.3% of cases, and 97.1% of ticagrelor patients also received verapamil, yielding an overall co‑exposure rate of 32.4%. Ticagrelor...
The Utilisation of Endocrine and Immunotherapy: Retrospective Study at a Tertiary Hospital in South Africa
A retrospective study of 82 cancer patients at a Limpopo tertiary hospital found endocrine therapy used as first‑line or adjuvant treatment in 29.3% of cases, while immunotherapy was virtually absent, administered to only five patients overall. Significant associations emerged between...
Normative Values of Evans’ Index and Cranial Dimensions on Brain CT Scans: Age- and Sex-Related Variations in a Southeastern Nigerian...
A retrospective analysis of 676 normal cranial CT scans from a southeastern Nigerian hospital established age‑ and sex‑specific normative values for Evans’ Index (EI). The overall median EI was 0.28 with a 95 % range of 0.22–0.32, and EI rose steadily...
TENS Pulses Defeat Fibromyalgia Pain and Fatigue
A real‑world trial involving 384 fibromyalgia patients showed that adding transcutaneous electrical nerve stimulation (TENS) to standard outpatient physical therapy significantly lowered movement‑evoked pain and, uniquely, reduced fatigue. The PT‑TENS group experienced a 1.2‑point drop on a 0‑10 pain scale...
The Doctor Is In—Breach: Five Pitfalls in Physician Employment Agreements
The article outlines five common pitfalls in physician employment agreements, ranging from overbroad restrictive covenants to vague compensation formulas, misclassification of physicians, unclear termination terms, and insufficient regulatory clauses. State-by-state limits on non‑competes—such as bans in Alabama and Rhode Island...
AI Therapist Dzeny Cuts Anxiety 43% in Eight‑Week Trial of 280 Adults
A clinical trial of Dzeny’s AI‑assisted therapist showed participants’ anxiety scores fell 43% in eight weeks, a result comparable to conventional cognitive‑behavioral therapy. The study, led by psychologist Valentina Lipskaya, also reported gains in burnout, mood and quality of life,...
Study Finds Repetitive Meals and Stable Calories Boost Weight‑Loss by Up to 6%
Researchers analyzing daily food logs from 112 overweight adults in a 12‑week behavioral program found that participants who ate the same foods repeatedly and kept daily calories steady lost 5.9% of body weight, versus 4.3% for those with varied diets....
UT San Antonio Starts Precision Rapamycin Trial for Healthy Aging
The University of Texas at San Antonio has opened a precision clinical trial to evaluate rapamycin in non‑smoking, independently living seniors. Researchers hope the study will provide hard data on dosing and safety, moving the longevity drug from hype to...
US Obesity Prevalence Rises to 69% with New Metrics
Obesity (in the US) is much more common than prev thought: 69% vs. old 43% stat Based on new better definition that uses not only BMI but also anthropomorphic measures such as waist & ratios of it, which more accurately shows higher...
Security Gaps Exposed in Pharma AI Research Platforms Amid Rising Cyber Risks
A recent industry report warns that AI‑driven drug discovery platforms are vulnerable to cyber‑attacks and data‑privacy breaches, citing outdated hardware, fragmented compliance frameworks, and supply‑chain pressures. The findings could force pharma firms to overhaul security protocols and accelerate regulatory engagement.
West Suburban Medical Center in Oak Park Shuts Down Abruptly over EMR Payroll Glitch
West Suburban Medical Center in Oak Park halted all patient care and furloughed many employees after its year‑old electronic medical record (EMR) system failed to process payroll. Owner Manoj Prasad cited the broken system as the trigger, leaving a 234‑bed...
GlucoTrack Shares Jump 34% as FDA IDE Submission Looms for Implantable Glucose Monitor
GlucoTrack, Inc. saw its Nasdaq‑listed shares climb 34.09% to $1.46 after reporting key milestones that set the stage for an Investigational Device Exemption (IDE) filing with the FDA in the second quarter of 2026. The company completed a first‑in‑human trial...
#AAD26: Tanabe’s Phase 3 Win for Drug Targeting Rare Diseases that Cause Pain upon Light Exposure
Tanabe Pharma announced that its oral investigational drug achieved positive results in a pivotal Phase 3 trial for erythropoietic protoporphyria (EPP) and X‑linked protoporphyria (XLP), two ultra‑rare phototoxic disorders. The study met its primary endpoint of reducing light‑induced pain episodes and...
HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE
The HI‑PEITHO trial showed that ultrasound‑facilitated, catheter‑directed fibrinolysis combined with heparin cuts the 7‑day composite risk of PE‑related death, cardiorespiratory decompensation or collapse by 61% versus anticoagulation alone. In 544 intermediate‑risk pulmonary embolism patients, the number needed to treat was...
Listening to Music for 24 Minutes May Ease Anxiety, Study Finds
Researchers at Toronto Metropolitan University discovered that a 24‑minute session of music combined with auditory beat stimulation (ABS) significantly reduces anxiety symptoms in adults already taking medication. In a randomized trial of 144 participants, the 24‑minute condition outperformed a 12‑minute...
Occupational Therapy in Addiction Recovery: Making Daily Life Livable
Irving Gold argues that occupational therapists (OTs) are the missing link in Canada’s addiction recovery system, which currently over‑invests in crisis care and under‑invests in everyday support. He describes how OTs address both the underlying mental‑health drivers and the practical...
Taxpayers Fund Everything Except Our Health Debt
Let me help rephrase for you Bernie. Need a loan for college so you can party for a semester and drop out? Taxpayers will loan you money for it. Need an SBA loan for your business ? Taxpayers will...
Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension
Anumana has secured FDA 510(k) clearance for its AI‑driven pulmonary hypertension (PH) algorithm, the first software‑as‑a‑medical‑device that analyzes standard 12‑lead ECGs to flag early PH signs. The tool, built on more than 250,000 de‑identified ECGs from Mayo Clinic, demonstrated roughly...
WHO Moves to Launch Global Vaccine Passport System with Firm Linked to Pfizer, Bill Gates
The World Health Organization announced a partnership with Singapore’s state‑owned investment firm Temasek to develop interoperable digital health wallets, beginning with vaccine and prophylaxis certificates in the 11 ASEAN member states. The effort builds on recent International Health Regulations amendments...
Spatial Mapping Technique Allows Researchers to Understand Tumor Architecture
University of Illinois Urbana‑Champaign researchers unveiled GIS‑ROTA, a Geographic Information System‑augmented spatial transcriptomics framework that visualizes biological pathway activity inside tumors. Applied to estrogen‑receptor‑positive breast cancer, the method exposed distinct spatial patterns differentiating primary from metastatic lesions and highlighted regions...
Why Physician Burnout Is Actually a Loss of Professional Identity
Physician burnout is increasingly recognized as a loss of professional identity rather than mere exhaustion. Drawing on Heinz Kohut’s psychoanalytic framework, the article identifies three invisible supports—mirroring, idealization, and twinship—that sustain doctors’ sense of self. Modern health‑care systems erode these...
Brain Scans Reveal How Poor Sleep Fuels Negative Emotions in Alcohol Addiction
A new study in Drug and Alcohol Dependence examined 115 adults with alcohol use disorder (AUD) and found that poor sleep is strongly associated with heightened negative emotions, but not with craving or executive function. Functional MRI revealed that poor...
Second-Hand Smoke Exposure Down 96% Since Scotland's Smoking Ban, Study Shows
Scotland’s 2006 smoke‑free law has cut second‑hand smoke exposure by 96%, according to a University of Stirling and Public Health Scotland study analyzing salivary cotinine data from 1998‑2024. Average cotinine levels in non‑smokers dropped 95.7%, and the share of smoke‑free...
Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition From Oral Atypical Antipsychotics to Cobenfy™ (Xanomeline and Trospium Chloride)
Bristol Myers Squibb reported Phase 4 data showing that adults with schizophrenia can switch from oral atypical antipsychotics to Cobenfy (xanomeline‑trospium) without loss of symptom control. In an 8‑week open‑label trial, 86% of 105 patients completed the study, and mean PANSS...
Mechanical Circulatory Support Doesn’t Reduce Infarct Size in STEMI
The STEMI Door‑to‑Unload trial showed that using the Impella CP device 30 minutes before primary PCI in anterior STEMI patients without cardiogenic shock did not reduce infarct size compared with PCI alone, and it increased major bleeding and vascular complications. The study...
Teledermatology Expands Patient Access, Reimbursement Opportunities
Teledermatology usage remains steady, with 63% of dermatologists adopting it in 2022 and about 60% continuing virtual care in 2025, primarily via live video. Experts at the 2026 AAD Annual Meeting highlighted telehealth as a revenue‑protective tool amid Medicare’s 2.5%...
GLP‑1 Drugs Could Help Prevent Cancer, Study Shows
As a medical school professor, I've watched GLP-1 drugs transform diabetes and obesity treatment. Now a Nature Cancer review reveals they may suppress cancer too. GLP-1 drugs reduce insulin resistance, lower inflammation, and cut body weight -- three of the biggest...
MARCUS: First Visual Language Model for Cardiac Imaging
MARCUS, the first visual language model trained on raw ECG, echocardiography, and MRI video imaging data that reasons interactively with clinicians. From @EuanAshley et al @StanfordMed https://t.co/nlwXin0G1b
The MATCH Monopoly and What It Actually Means for Health Tech
Congressional scrutiny of the National Resident Matching Program’s (NRMP) antitrust exemption intensified after a May 2025 hearing, highlighting wage suppression and a persistent residency bottleneck. In 2025, 52,498 medical students competed for 43,237 slots, leaving roughly 9,000 unmatched, while average...
Classifying Aging Doesn't Affect Need for Research Investment
Though authors acknowledge (as I have argued before), even *if* they are right, “classification of aging is not relevant to the importance of investing in aging research to alleviate its burden” [nor targeting it, I might add] 👨🏻⚕️
US Health Care Costs Begin to Flatten, Tech Helps
Will generate discussion: new @BrookingsInst report from David Cutler & @LevKlarnet (h/t @peter_orszag) suggesting early evidence that we're starting to bend US HC $ curve https://t.co/KUH3muQRFz @ScottGottliebMD @amitabhchandra2 One potential factor: tech... @DanielSodickson https://t.co/Ux1PT7QsgU
Biological Age Outperforms Chronological Age in Outcome Prediction
In the era of molecular and organ clocks and marked inter- and infra-individual variability of the aging process, we need to move beyond chronological age. "biologic measures predict outcomes more robustly than chronologic age" @NEJM https://t.co/DKmIfdJJUF https://t.co/d5Gc6xGKqn